World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01612650
Date of registration: 04/06/2012
Prospective Registration: No
Primary sponsor: Centre Oscar Lambret
Public title: Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis TOMOSEIN
Scientific title: Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis
Date of first enrolment: February 24, 2012
Target sample size: 1069
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01612650
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Screening. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Sophie TAIEB, MD
Address: 
Telephone:
Email:
Affiliation:  Oscar Lambret Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- woman with breast cancer histologically proven (group 1), on surveillance of a treated
breast cancer (group 2) or diagnosis of an detected anomaly

- age = 40 years (group 1, group 2); age = 50 years (group 3)

- breast size suitable for detector size

- possible prior mastectomy

- security social covered

- signed informed consent

Exclusion Criteria:

- breast implant

- high genetic risk (mutation)

- under justice measures

- breast feeding or pregnant woman



Age minimum: 40 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
3D Mammography
2D Mammography
Breast Cancer
Intervention(s)
Device: 2D mammography
Device: tomosynthesis
Primary Outcome(s)
determine the benefit of tomosynthesis for diagnosis [Time Frame: 30 months]
Secondary Outcome(s)
determine best incidence of realization [Time Frame: 30 months]
evaluate non focused ultrasound residual place for 2 - 3 - 4 density breast [Time Frame: 30 months]
number of additional cancer detected by tomosynthesis [Time Frame: 30 months]
measurement of breast irradiation [Time Frame: 30 months]
Secondary ID(s)
2011-002051-34
TOMOSEIN-1104
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history